Menu
GeneBe

rs142206385

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_182914.3(SYNE2):c.15446G>A(p.Arg5149His) variant causes a missense change. The variant allele was found at a frequency of 0.000198 in 1,614,186 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R5149C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00030 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00019 ( 0 hom. )

Consequence

SYNE2
NM_182914.3 missense

Scores

5
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 4.75
Variant links:
Genes affected
SYNE2 (HGNC:17084): (spectrin repeat containing nuclear envelope protein 2) The protein encoded by this gene is a nuclear outer membrane protein that binds cytoplasmic F-actin. This binding tethers the nucleus to the cytoskeleton and aids in the maintenance of the structural integrity of the nucleus. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
ESR2 (HGNC:3468): (estrogen receptor 2) This gene encodes a member of the family of estrogen receptors and superfamily of nuclear receptor transcription factors. The gene product contains an N-terminal DNA binding domain and C-terminal ligand binding domain and is localized to the nucleus, cytoplasm, and mitochondria. Upon binding to 17beta-estradiol or related ligands, the encoded protein forms homo- or hetero-dimers that interact with specific DNA sequences to activate transcription. Some isoforms dominantly inhibit the activity of other estrogen receptor family members. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been fully characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.030840695).
BP6
Variant 14-64143911-G-A is Benign according to our data. Variant chr14-64143911-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 860889.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1, Benign=1}.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000295 (45/152304) while in subpopulation AMR AF= 0.000785 (12/15296). AF 95% confidence interval is 0.000452. There are 0 homozygotes in gnomad4. There are 29 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
High AC in GnomAd at 45 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SYNE2NM_182914.3 linkuse as main transcriptc.15446G>A p.Arg5149His missense_variant 83/116 ENST00000555002.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SYNE2ENST00000555002.6 linkuse as main transcriptc.15446G>A p.Arg5149His missense_variant 83/1161 NM_182914.3 P4Q8WXH0-2

Frequencies

GnomAD3 genomes
AF:
0.000296
AC:
45
AN:
152186
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000786
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00151
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000239
AC:
60
AN:
251328
Hom.:
0
AF XY:
0.000221
AC XY:
30
AN XY:
135812
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000347
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000109
Gnomad SAS exome
AF:
0.0000653
Gnomad FIN exome
AF:
0.00134
Gnomad NFE exome
AF:
0.000114
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000188
AC:
275
AN:
1461882
Hom.:
0
Cov.:
31
AF XY:
0.000180
AC XY:
131
AN XY:
727244
show subpopulations
Gnomad4 AFR exome
AF:
0.0000597
Gnomad4 AMR exome
AF:
0.000335
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0000464
Gnomad4 FIN exome
AF:
0.000749
Gnomad4 NFE exome
AF:
0.000181
Gnomad4 OTH exome
AF:
0.000182
GnomAD4 genome
AF:
0.000295
AC:
45
AN:
152304
Hom.:
0
Cov.:
32
AF XY:
0.000389
AC XY:
29
AN XY:
74474
show subpopulations
Gnomad4 AFR
AF:
0.000120
Gnomad4 AMR
AF:
0.000785
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00151
Gnomad4 NFE
AF:
0.000162
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000189
Hom.:
0
Bravo
AF:
0.000189
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000173
AC:
21
EpiCase
AF:
0.000273
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Emery-Dreifuss muscular dystrophy 5, autosomal dominant Uncertain:1Benign:2
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 15, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvityJan 13, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.32
Cadd
Benign
23
Dann
Uncertain
1.0
Eigen
Benign
0.083
Eigen_PC
Benign
0.15
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.80
T;T;T;T;T
M_CAP
Benign
0.023
T
MetaRNN
Benign
0.031
T;T;T;T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
0.60
N;.;N;.;.
MutationTaster
Benign
1.0
D;N;N;N;N;N;N
PrimateAI
Benign
0.45
T
PROVEAN
Uncertain
-3.5
D;.;D;D;D
REVEL
Benign
0.11
Sift
Uncertain
0.010
D;.;D;D;D
Sift4G
Uncertain
0.038
D;T;D;T;D
Polyphen
0.48
P;.;P;B;.
Vest4
0.46
MVP
0.39
MPC
0.34
ClinPred
0.11
T
GERP RS
4.4
Varity_R
0.095
gMVP
0.091

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs142206385; hg19: chr14-64610629; API